Imaging of Prostate Cancer Using 18F-Choline PET/Computed Tomography

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F17%3A73584670" target="_blank" >RIV/61989592:15110/17:73584670 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1016/j.cpet.2016.11.004" target="_blank" >http://dx.doi.org/10.1016/j.cpet.2016.11.004</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.cpet.2016.11.004" target="_blank" >10.1016/j.cpet.2016.11.004</a>

Result language
angličtina
Original language name
Imaging of Prostate Cancer Using 18F-Choline PET/Computed Tomography
Original language description
18F-fluorocholine (FCH) PET/computed tomography (CT) is a valuable imaging modality in prostate cancer disease. Probably, its main role is restaging of patients with biochemical recurrence after radical prostatectomy or external beam radiotherapy. 18F-FCH PET/CT is strengthening its position in the initial staging, biopsy target definition, radiotherapy planning, and therapy monitoring. Gleason score and prostate-specific antigen value, doubling time, and velocity can influence positivity of 18F-FCH PET/CT. The influence of androgen deprivation therapy on choline uptake is not precisely clarified. Collaboration between nuclear medicine physicians, radiologists, urologists, oncologists, and radiotherapists is crucial to help patients with prostate cancer disease.
Czech name
—
Czech description
—

Type
J<sub>SC</sub> - Article in a specialist periodical, which is included in the SCOPUS database
CEP classification
—
OECD FORD branch
30224 - Radiology, nuclear medicine and medical imaging

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)